Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (241-250 of 382) with videos related to

Pageof 39
Sort By:
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Protocol for the examination of specimens from patients with tumors of boneBrian P Rubin, Cristina R Antonescu, Francis H Gannon, et al.
American Journal of Hematology|March 16, 2010
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphomaPatrick B Johnston, David J Inwards, Joseph P Colgan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2016
Immunologic Autograft Engineering and Survival in Non-Hodgkin LymphomaLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Leukemia & Lymphoma|November 22, 2011
The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphomaRyan A Wilcox, Kay Ristow, Thomas M Habermann, et al.
Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.
Annals of Surgical Oncology|December 15, 2010
Surgical approach and oncologic outcomes following multidisciplinary management of retrorectal sarcomasEric J Dozois, David J Jacofsky, Brian J Billings, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Pageof 39

Showing results (241-250 of 382) with videos related to

Sort By:
Pageof 39
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Archives of Pathology & Laboratory Medicine|April 7, 2010
Protocol for the examination of specimens from patients with tumors of boneBrian P Rubin, Cristina R Antonescu, Francis H Gannon, et al.
American Journal of Hematology|March 16, 2010
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphomaPatrick B Johnston, David J Inwards, Joseph P Colgan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2016
Immunologic Autograft Engineering and Survival in Non-Hodgkin LymphomaLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Leukemia & Lymphoma|November 22, 2011
The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphomaRyan A Wilcox, Kay Ristow, Thomas M Habermann, et al.
Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.
Annals of Surgical Oncology|December 15, 2010
Surgical approach and oncologic outcomes following multidisciplinary management of retrorectal sarcomasEric J Dozois, David J Jacofsky, Brian J Billings, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Pageof 39